51
|
Kang J, Men Y, Wang J, Zhai Y, Deng L, Wang W, Liu W, Wang X, Bi N, Xiao Z, Liang J, Lv J, Zhou Z, Feng Q, Chen D, Wang L, Hui Z. Optimal Timing of Postoperative Radiotherapy (PORT) for Patients with pⅢA-N2 Non-Small Cell Lung Cancer (NSCLC) Receiving Complete Resection Followed by Adjuvant Chemotherapy. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.1293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
52
|
Wang X, Zhang T, Deng L, Wang W, Liu W, Wang J, Zhai Y, Feng Q, LV J, Xiao Z, Chen D, Zhou Z, Bi N. Serial Circulating Tumor DNA for Evaluating Early Response During Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: Preliminary Analysis of a Prospective Biomarker Study. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.2242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
53
|
Deng L, Hui Z, Men Y, Kang J, Sun X, Wang J, Wang W, Bi N, Zhou Z, Xiao Z. The Efficacy of Local Radiotherapy after Failure of First-Line Treatment for Piiia-N2 Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.1312] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
54
|
Wu M, Ling H, Bi N, Gao S, Hu Q, Sheng H, Yu J. Visual Tracking with Multiview Trajectory Prediction. IEEE TRANSACTIONS ON IMAGE PROCESSING : A PUBLICATION OF THE IEEE SIGNAL PROCESSING SOCIETY 2020; PP:8355-8367. [PMID: 32790628 DOI: 10.1109/tip.2020.3014952] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Recent progresses in visual tracking have greatly improved the tracking performance. However, challenges such as occlusion and view change remain obstacles in real world deployment. A natural solution to these challenges is to use multiple cameras with multiview inputs, though existing systems are mostly limited to specific targets (e.g. human), static cameras, and/or require camera calibration. To break through these limitations, we propose a generic multiview tracking (GMT) framework that allows camera movement, while requiring neither specific object model nor camera calibration. A key innovation in our framework is a cross-camera trajectory prediction network (TPN), which implicitly and dynamically encodes camera geometric relations, and hence addresses missing target issues such as occlusion. Moreover, during tracking, we assemble information across different cameras to dynamically update a novel collaborative correlation filter (CCF), which is shared among cameras to achieve robustness against view change. The two components are integrated into a correlation filter tracking framework, where features are trained offline using existing single view tracking datasets. For evaluation, we first contribute a new generic multiview tracking dataset (GMTD) with careful annotations, and then run experiments on the GMTD and CAMPUS datasets. The proposed GMT algorithm shows clear advantages in terms of robustness over state-of-the-art ones.
Collapse
|
55
|
Xu J, Zhang B, Jia L, Bi N, Zhao T. Metal-enhanced fluorescence detection and degradation of tetracycline by silver nanoparticle-encapsulated halloysite nano-lumen. JOURNAL OF HAZARDOUS MATERIALS 2020; 386:121630. [PMID: 31744725 DOI: 10.1016/j.jhazmat.2019.121630] [Citation(s) in RCA: 41] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/27/2019] [Revised: 10/28/2019] [Accepted: 11/05/2019] [Indexed: 06/10/2023]
Abstract
The ultrasensitive detection and efficient degradation of tetracycline (TC) residues are important for improving food safety and protecting human health. In this paper, a smart silver-enhanced fluorescence platform for the ultrasensitive detection of TC was constructed via a simple and selective modification of the interior and external tubes of natural halloysite nanotubes. The thick pipe wall of this platform provides a natural defense and promotes metal-enhanced fluorescence effects, which subsequently accelerates the detection of TC. Moreover, the nanoplatform of the modified Ag nanoparticles can induce the separation of electrons and holes, thereby enhancing photocatalytic activity in TC degradation. This platform provides new opportunities for studying natural halloysite nanotubes and for simultaneously detecting and photodegrading other deleterious substances.
Collapse
|
56
|
Bi N, Chen J, Tan J. The Handwritten Chinese Character Recognition Uses Convolutional Neural Networks with the GoogLeNet. INT J PATTERN RECOGN 2019. [DOI: 10.1142/s0218001419400160] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
With the outstanding performance in 2014 at the ImageNet Large-Scale Visual Recognition Challenge 2014 (ILSVRC14), an effective convolutional neural network (CNN) model named GoogLeNet has drawn the attention of the mainstream machine learning field. In this paper we plan to take an insight into the application of the GoogLeNet in the Handwritten Chinese Character Recognition (HCCR) on the database HCL2000 and CASIA-HWDB with several necessary adjustments and also state-of-the-art improvement methods for this end-to-end approach. Through the experiments we have found that the application of the GoogLeNet for the Handwritten Chinese Character Recognition (HCCR) results into significant high accuracy, to be specific more than 99% for the final version, which is encouraging for us to further research.
Collapse
|
57
|
Zhai Y, Hui Z, Men Y, Liang J, Wang J, Feng Q, Zhou Z, Xiao Z, Bi N, Wang L. Concurrent Erlotinib and Radiotherapy for Chemotherapy- intolerant Esophageal Squamous Cell Carcinoma Patients: A Propensity Score-Matched Analysis. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.2040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
58
|
Zeng Q, Qinfu F, Zhai Y, Wang L, Xiao Z, Zhou Z, Bi N, Liang J, Hui Z. Treatment and Prognosis of Thymic Neuroendocrine Neoplasms. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.1396] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
59
|
Wang J, Zhang T, Chen X, Xia W, Miao J, Zhou Z, Dai J, Bi N. Deep-learning Based Automatic Delineation Improves CTV Contouring Quality and Efficiency for Pathological N2 (pN2) Non-small Cell Lung Cancer (NSCLC) Receiving Post-operation Radiation Therapy. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
60
|
Wang D, Bi N, Zhang T, Zhou Z, Xiao Z, Liang J, Chen D, Hui Z, Feng Q, Wang L. Comparison of the Efficacy and Toxicities for Locally Advanced Non-Small Cell Lung Cancer Treated By Simultaneous Integrated Boost Intensity-Modulated Radiotherapy or Conventional Intensity-Modulated Radiotherapy: A Retrospective Study of 426 Patients. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.472] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
61
|
Deng L, Hui Z, Men Y, Kang J, Sun X, Wang J, Wang W, Bi N, Zhou Z, Xiao Z. Simple OS Risk Score Classification in Resected Pathological Stage IIIA-N2 Non-Small Cell Lung Cancer Patients before Postoperative Radiotherapy: A Prediction Model. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.1320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
62
|
Zhai Y, Hui Z, Men Y, Feng Q, Zhou Z, Lv J, Wang W, Deng L, Zhang T, Wang X, Bi N, Wang L. TTF-1 Expression is Correlated with Necessity of Postoperative Radiotherapy in Stage IIIA-N2 Lung Adenocarcinoma. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.2459] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
63
|
Zhai Y, Feng Q, Gao Y, Hui Z, Zhou Z, Xiao Z, Zhang Y, Lv J, Bi N, Wang L, He J. THYPORT: Postoperative Radiotherapy Versus Surgery Alone in Masaoka Stage II Thymoma: Mid-Term Result of a Prospective Randomized Study from a Single Center(NCT 02014805). Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.1397] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
64
|
Wang J, Men Y, Kang J, Sun X, Deng L, Zhai Y, Wang W, Bi N, Liang J, Lv J, Zhou Z, Feng Q, Xiao Z, Chen D, Wang L, Zhao J, Hui Z. Impact of Radiotherapy on Predictive Value of Systematic Inflammation-immune Score in Patients with pN2 Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.2452] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
65
|
Ni W, Xiao Z, Zhou Z, Wang X, Chen D, Qinfu F, Liang J, LV J, Bi N, Deng L, Zhang T, Wang W. A Phase II/III Randomized Controlled Trial of Adjuvant Radiotherapy, Concurrent Chemoradiotherapy after Surgery Versus Surgery Alone in Patients with Stage ⅡB-Ⅲ Esophageal Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.2109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
66
|
Sun X, Hui Z, Men Y, Kang J, Yuan M, Liang J, Feng Q, Zhou Z, Xiao Z, Lv J, Bi N, Deng L, Wang W, Zhang T, Wang X, Wang L. Patterns of Local-Regional Failure (LRF) in Completely Resected pⅢA-N2 Non-Small Cell Lung Cancer (NSCLC) after Adjuvant Chemotherapy and Postoperative Radiotherapy (PORT). Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.2441] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
67
|
Wang X, Wang X, Ge X, Zhang W, Zhou H, Qie S, Lin Y, Hu M, Hao C, Liu K, Zhao Y, Sun X, Pang Q, Li M, Liu M, Chen J, Zhang K, Li L, Ni W, Chang X, Han W, Deng W, Deng L, Bi N, Zhang T, Wang W, Liang J, Zhou Z, Xiao Z. S-1 Based Simultaneous Integrated Boost Radiotherapy Followed by Consolidation Chemotherapy with S-1 for Esophageal Squamous Cell Carcinoma in the Elderly – A Multicenter Phase II Study (3JECROG P-01). Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
68
|
Wang W, Zhou Z, Deng L, Wang J, Bi N, Zhang T. Phase II Clinical Trial of Hippocampal-Sparing Whole Brain Irradiation and Simultaneous Integrated Boost Tomotherapy (SIB-TOMO) for Brain Metastases in Patients with Lung Cancer. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.1288] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
69
|
Shi Y, Lv Z, Bi N, Zhang C. An improved SIFT algorithm for robust emotion recognition under various face poses and illuminations. Neural Comput Appl 2019. [DOI: 10.1007/s00521-019-04437-w] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
70
|
Su Y, Li W, Bi N, Lv Z. Adolescents Environmental Emotion Perception by Integrating EEG and Eye Movements. Front Neurorobot 2019; 13:46. [PMID: 31293410 PMCID: PMC6606730 DOI: 10.3389/fnbot.2019.00046] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2018] [Accepted: 06/11/2019] [Indexed: 11/13/2022] Open
Abstract
Giving a robot the ability to perceive emotion in its environment can improve human-robot interaction (HRI), thereby facilitating more human-like communication. To achieve emotion recognition in different built environments for adolescents, we propose a multi-modal emotion intensity perception method using an integration of electroencephalography (EEG) and eye movement information. Specifically, we first develop a new stimulus video selection method based on computation of normalized arousal and valence scores according to subjective feedback from participants. Then, we establish a valence perception sub-model and an arousal sub-model by collecting and analyzing emotional EEG and eye movement signals, respectively. We employ this dual recognition method to perceive emotional intensities synchronously in two dimensions. In the laboratory environment, the best recognition accuracies of the modality fusion for the arousal and valence dimensions are 72.8 and 69.3%. The experimental results validate the feasibility of the proposed multi-modal emotion recognition method for environment emotion intensity perception. This promising tool not only achieves more accurate emotion perception for HRI systems but also provides an alternative approach to quantitatively assess environmental psychology.
Collapse
|
71
|
Ni WJ, Yu SF, Yang JS, Zhang WC, Zhou ZM, Zhang HX, Chen DF, Feng QF, Lyu JM, Liang J, Wang XZ, Wang X, Deng L, Wang WQ, Zhang T, Bi N, Xiao ZF. [Study on safety of adjuvant radiotherapy concurrent with weekly chemotherapy for stage ⅡB-ⅣA esophageal carcinoma after radical resection]. ZHONGHUA ZHONG LIU ZA ZHI [CHINESE JOURNAL OF ONCOLOGY] 2019; 41:415-420. [PMID: 31216826 DOI: 10.3760/cma.j.issn.0253-3766.2019.06.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To evaluate the tolerability and short-term efficacy of chemo-radiotherapy in 125 patients with stage ⅡB-ⅣA esophageal carcinoma after radical resection. Methods: We retrospectively evaluated the rate of completion, toxicity and survival of patients undergoing adjuvant concurrent chemo-radiotherapy after radical resection of esophageal carcinoma from January 2004 to December 2014 in our institution. The survival rate was determined by the Kaplan-Meier method and analyzed using the log-rank test. Multivariate prognostic analysis was performed using the Cox proportional hazard model. Results: 122 patients received more than 50 Gy dose (97.6%). A total of 52 patients received more than 5 weeks chemo-radiotherapy (41.6%), while 73 patients underwent only 1-4 weeks (58.4%). The median following up was 48.4 months. 8 patients lost follow up (6.4%). The 1-year and 3-year overall survival rate were 91.6% and 57.0%, respectively, with a median survival time of 64.4 months. The 1-year and 3-year disease free survival rate were 73.2% and 54.3%, respectively, with a median disease free survival time of 59.1 months. The most common acute complications associated with chemo-radiotherapy were myelosuppression, radiation esophagitis and radiation dermatitis, the majority of which were Grade 1-2. Of the 125 patients, there were 59 cases of recurrence, including 23 cases with local regional recurrence, 26 cases with hematogenous metastasis, and 8 cases with mixed recurrence. Univariate analysis showed that the numbers of concurrent chemotherapy was associated with the overall survival (P=0.006). But receiving more than 5 weeks was not the prognostic factor compared to 1 to 4 weeks chemotherapy (P=0.231). Multivariate analysis showed that only the numbers of concurrent chemotherapy was an independent prognostic factor (P=0.010). Conclusions: Postoperative radiotherapy concurrent with weekly chemotherapy could improve the overall survival and decrease the recurrence for stage ⅡB-ⅣA esophageal carcinoma after radical resection. However, the completion rate of chemotherapy was low, so it was necessary to explore reasonable regimens to improve the completion rate and carry out prospective randomized controlled trial.
Collapse
|
72
|
Zhang B, Bi N, Zhang C, Gao X, Lv Z. Robust EOG-based saccade recognition using multi-channel blind source deconvolution. ACTA ACUST UNITED AC 2019; 64:309-324. [PMID: 29975664 DOI: 10.1515/bmt-2018-0018] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2017] [Accepted: 06/08/2018] [Indexed: 11/15/2022]
Abstract
Human activity recognition (HAR) is a research hotspot in the field of artificial intelligence and pattern recognition. The electrooculography (EOG)-based HAR system has attracted much attention due to its good realizability and great application potential. Focusing on the signal processing method of the EOG-HAR system, we propose a robust EOG-based saccade recognition using the multi-channel convolutional independent component analysis (ICA) method. To establish frequency-domain observation vectors, short-time Fourier transform (STFT) is used to process time-domain EOG signals by applying the sliding window technique. Subsequently, we apply the joint approximative diagonalization of eigenmatrix (JADE) algorithm to separate the mixed signals and choose the "clean" saccadic source to extract features. To address the problem of permutation ambiguity in a case with a six-channel condition, we developed a constraint direction of arrival (DOA) algorithm that can automatically adjust the order of eye movement sources according to the constraint angle. Recognition experiments of four different saccadic EOG signals (i.e. up, down, left and right) were conducted in a laboratory environment. The average recognition ratios over 13 subjects were 95.66% and 97.33% under the between-subjects test and the within-subjects test, respectively. Compared with "bandpass filtering", "wavelet denoising", "extended infomax algorithm", "frequency-domain JADE algorithm" and "time-domain JADE algorithm, the recognition ratios obtained relative increments of 4.6%, 3.49%, 2.85%, 2.81% and 2.91% (within-subjects test) and 4.91%, 3.43%, 2.21%, 2.24% and 2.28% (between-subjects test), respectively. The experimental results revealed that the proposed algorithm presents robust classification performance in saccadic EOG signal recognition.
Collapse
|
73
|
Ni WJ, Deng W, Xiao ZF, Zhou ZM, Wang X, Chen DF, Feng QF, Liang J, Lyu JM, Bi N, Deng L, Zhang T, Wang WQ, Xue Q, Gao SG, Mu JW, Mao YS, Wang DL, Zhao J, Gao YS, Huang JF, Tan FW, Zhao L, Lyu F, Zhang GC. [The value of the planned neoadjuvant radiotherapy or chemoradiotherapy for the non-radical resection of esophageal squamous cell carcinoma]. ZHONGHUA ZHONG LIU ZA ZHI [CHINESE JOURNAL OF ONCOLOGY] 2019; 41:295-302. [PMID: 31014056 DOI: 10.3760/cma.j.issn.0253-3766.2019.04.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: The role of planned neoadjuvant radiotherapy or chemoradiotherapy in the non-radical resection of esophageal squamous cell carcinoma was unclear. The study aimed to evaluate their therapeutic effect and analyze the prognostic factors. Methods: We retrospectively analyzed the clinical data of locally advanced esophageal squamous cell carcinoma who received neoadjuvant radio therapy (33 patients) and concurrent chemoradiotherapy (119 patients) from January 2004 to December 2016 in our single-institution database.The survival rates were calculated by Kaplan-Meier method. The prognostic factors were analyzed by using Log rank test and Cox proportional hazards model. Results: The median follow-up was 29.8 months. One hundred and one patients survived more than 3 years. The rates of overall survival (OS) and disease-free survival (DFS) at 3 years were 63.9% and 55.6%, respectively.The rates of complete, partial and minimal pathological response of the primary tumor were 50.3%, 38.4%, 11.3%, the corresponding 3-year OS were 75.5%, 57.4%, 27.3% (P<0.001) and 3-year DFS were 72.0%, 44.7%, 17.6% (P<0.001), respectively.The postoperative lymph node metastasis rate was 27.0%. The 3-year OS and DFS of the lymph node positive group was 45.6% and 32.8%, significantly lower than 70.8% and 63.7% of the negative group (both P<0.001). The 3-year OS and DFS of pathologic stage Ⅰ, Ⅱ, ⅢA, ⅢB and Ⅵ A were 76.2%, 57.4%, 64.7%, 35.0%, 33.3% (P<0.001) and 70.1%, 49.3%, 41.2%, 22.1%, 33.3% (P<0.001), respectively.The operation-related mortality was 3.3%. Multivariate analysis showed that chest pain, postoperative respiratory failure, pathological differentiation, more than 15 lymph node dissection and ypTNM stage were the independent prognostic factors of OS (P<0.05 for all). Conclusions: The planned neoadjuvant radiotherapy or chemoradiotherapy for the non-radical resection of advanced esophageal squamous cell carcinoma could result in favorable survival. The chest pain, postoperative respiratory failure, pathological differentiation, the number of lymph node resection and ypTNM stage are the independent prognostic factors of the prognosis of these patients.
Collapse
|
74
|
Bi N, Suen CY, Nobile N, Tan J. A multi-feature selection approach for gender identification of handwriting based on kernel mutual information. Pattern Recognit Lett 2019. [DOI: 10.1016/j.patrec.2018.05.005] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
75
|
Xu J, Shen XK, Jia L, Cao JL, Wang Y, Zhao XL, Bi N, Guo SL, Ma TY. A lanthanide-based magnetic nanosensor as an erasable and visible platform for multi-color point-of-care detection of multiple targets and the potential application by smartphone. J Mater Chem B 2019; 7:734-743. [DOI: 10.1039/c8tb02791a] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A magnetic Fe3O4@CePO4:Tb-EDTA-Eu nanosensor as an erasable and visible platform for the multi-color detection of multiple targets was designed.
Collapse
|
76
|
Zhai Y, Hui Z, Liang J, Feng Q, Bi N, Xiaozhen W, Zhou Z, Men Y, Wang L. Serum MicroRNAs in Predicting the Efficacy of Chemoradiotherapy for Locally Advanced Esophageal Squamous Carcinoma. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
77
|
Hawkins P, Sun Y, Dess R, Jackson W, Sun G, Bi N, Tewari M, Hayman J, Kalemkerian G, Lawrence T, Haken RT, Matuszak M, Kong F, Schipper M, Jolly S. Circulating microRNAs as Biomarkers of Radiation-Induced Cardiac Toxicity in Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.06.341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
78
|
Wang J, Men Y, Kang J, Sun X, Deng L, Zhai Y, Wang W, Bi N, Wang X, Liang J, Lv J, Zhou Z, Feng Q, Xiao Z, Chen D, Yin W, Wang L, Zhao J, Hui Z, Hui Z. Significance of Systemic Immune-inflammation Status as a Prognostic Indicator in Resected Non-small Cell Lung Cancer with Pathological N2 Nodal Involvement. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.1910] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
79
|
Wang C, Lu X, Zhou Z, Bi N, Wang J, Hui Z, Liang J, Feng Q, Chen D, Xiao Z, Lv J, Wang X, Wang X, Zhang T, Deng L, Wang W, Xiao J, Li J, Wang L. Upfront Radiation Therapy with TKI Improved the Intracranial PFS but Not OS in the NSCLC Patients Harboring EGFR Mutation and Brain Metastases. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.168] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
80
|
Lu X, Wang J, Wang C, Bi N, Zhou Z, Wang Y, Wang L. First-line Radical Local Therapy May Provide Additional Survival Gain for Patients with EGFR-mutant Metastatic Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.1866] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
81
|
Yang S, Xiao J, Ma Y, Zhao R, Zhang H, Liu Q, Zhang Y, Bi N, Li Y. Treatment of Complex Brain Metastases with Helical Tomotherapy: Results of a Phase II Trial. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.1123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
82
|
Lu X, Wang J, Wang C, Bi N, Zhou Z, Wang Y, Wang L. P3.01-65 First-Line Radical Local Therapy May Provide Additional Survival Gain for Patients with EGFR-Mutant Metastatic NSCLC Receiving TKIs. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1625] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
83
|
Ma Y, Xiao J, Yang S, Zhao R, Zhang H, Xu Y, Tian Y, Bi N, Liu Q, Chen X, Yi J, Li Y. P05.24 The diagnosis and comprehensive treatment of leptomeningeal metastases--results of a phase II trial. Neuro Oncol 2018. [DOI: 10.1093/neuonc/noy139.350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
84
|
Ma Y, Xiao J, Bi N, Xu Y, Tian Y, Zhang H, Zhang Y, Liu Q, Zhao R, Yang S, Yi J, Li Y. P05.25 Helical tomotherapy for whole- brain irradiation with integrated boost to multiple brain metastases: dosimetric analysisandclinical outcomes. Neuro Oncol 2018. [DOI: 10.1093/neuonc/noy139.351] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
85
|
Dong X, Zhou ZM, Bi N, Wang JB, Ran JT, Hui ZG, Liang J, Feng QF, Chen DF, Xiao ZF, Lyu JM, Wang XZ, Wang X, Zhang T, Deng L, Wang WQ, Wang LH. [Prognostic value of pretreatment neutrophil-to-lymphocyte ratio (NLR) in locally advanced non-small cell lung cancer patients treated with thoracic radiation]. ZHONGHUA ZHONG LIU ZA ZHI [CHINESE JOURNAL OF ONCOLOGY] 2018; 40:446-451. [PMID: 29936771 DOI: 10.3760/cma.j.issn.0253-3766.2018.06.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: The aim of this retrospective study was to evaluate the prognostic significance of pretreatment Neutrophil-to-Lymphocyte Ratio(NLR) in locally advanced non-small cell lung cancer(NSCLC) patients treated with thoracic radiotherapy. Methods: We retrospectively analyze 420 patients who received thoracic radiotherapy alone, sequential chemoraiotherapy or concurrent chemoradiotherapy for locally advanced stage NSCLC from January 2007 to December 2010 of our hospital. The patients were divided into two groups (high NLR group and low NLR group) with appropriate cutoff point using the receiver operating characteristic (ROC) curve method. The survival curve was established by Kaplan-Meier method. The Log-rank test was used to compare the survival of the two NLR groups and the multivariate analysis was carried out by Cox regression model. Results: Among the 420 patients, 99 received radiotherapy alone, 139 received sequential chemoradiotherapy and 182 received concurrent chemoradiotherapy. 345 patients died and 75 were still alive. The median follow-up time was 5.2 years and the median overall survival was 22 months. The cut-off value of pretreatment NLR was 2.1. The 5-year PFS and OS rates in high NLR group and low NLR group were 10.6% vs 15.7% (P=0.033) and 15.5% vs 22.7% (P=0.012). Multivariate analysis confirmed that pretreatment NLR (hazard ratio 1.06, P=0.041) was independent prognostic factor of OS. Conclusions: Our study revealed that the pretreatment NLR is the independent prognostic factor of OS in patients with locally advanced stage NSCLC treated with thoracic radiotherapy. However, NLR is still greatly influenced by patient's condition and treatment which needs further research.
Collapse
|
86
|
Xu J, Shen X, Jia L, Zhou T, Ma T, Xu Z, Cao J, Ge Z, Bi N, Zhu T, Guo S, Li X. A novel visual ratiometric fluorescent sensing platform for highly-sensitive visual detection of tetracyclines by a lanthanide- functionalized palygorskite nanomaterial. JOURNAL OF HAZARDOUS MATERIALS 2018; 342:158-165. [PMID: 28826058 DOI: 10.1016/j.jhazmat.2017.08.020] [Citation(s) in RCA: 73] [Impact Index Per Article: 12.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/31/2017] [Revised: 08/02/2017] [Accepted: 08/08/2017] [Indexed: 06/07/2023]
Abstract
A palygorskite (Pal)-based ratiometric fluorescent nanoprobe is designed in order to establish a real time, on-site visual, and highly sensitive detection method for tetracyclines (TCs). The nanoprobe comprises the green emissive dye molecules embedded in the natural Pal, which serve as the internal reference signal. The potential red-emissive seed-europium (Eu3+) ions are covalently bound on the surface of modified Pal, and they can act as the specific recognition element. The emission intensity of Eu3+ ions significantly increases upon TC addition. The nanoprobe fluorescence changes from green to yellow, orange, or red, thereby accomplishing the visual ratiometric fluorescent detection. This nanoprobe exhibits a high sensitivity with a detection limit of 7.1nM and an excellent selectivity in monitoring the levels of TCs in milk samples. In addition, this nanoprobe is useful for quantitative determination of TCs, and it is not affected with intensity fluctuations due to instrumental or environmental factors. The nanoprobe-immobilized test paper realizes real-time TCs analysis by using a smartphone with an easy-to-access color-scanning APP as the detection platform. Moreover, the reported construction of visual ratiometric detection system follows the sustainable development idea, that is, from nature, for nature, and into the nature.
Collapse
|
87
|
Bi N, Liang J, Wang L. Response to ‘Survival advantage for etoposide/cisplatin over paclitaxel/carboplatin concurrent chemoradiation in patients with inoperable stage III NSCLC: a subgroup analysis for ECOG 2 patients would be of great interest’. Ann Oncol 2017; 28:3101-3103. [DOI: 10.1093/annonc/mdx533] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/30/2023] Open
|
88
|
Men Y, Zhai Y, Wu L, Liu L, Bi N, Song Y, Wang L. MiR-323a-3p Inhibits Cell Proliferation, Migration, and Invasion in Esophageal Squamous Cell Carcinoma Via Suppression FMR1. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.2069] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
89
|
Sun G, Ding X, Bi N, Wu L, Zhou W, Zhao Z, Wang J, Zhang W, Fan J, Zhang W, Dong X, Lv N, Zhan Q, Song Y, Wang L. miRNAs Associated With Brain Metastatic Lung Adenocarcinoma. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.2103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
90
|
Ma Y, Xiao J, Bi N, Zhang Y, Liu Q, Zhao R, Liu D, Yang S, Li Y. Temozolomide Combined with Fractionated Stereotactic Radiation Therapy for Large Brain Metastases: A Propensity-Matched Study. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.809] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
91
|
Ran J, Wang J, Bi N, Jiang W, Zhou Z, Hui Z, Liang J, Feng Q, Wang L. Health-Related Quality of Life in Long-Term Survivors of Unresectable Locally Advanced Non–small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.1906] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
92
|
Ni W, Yang J, Deng W, Xiao Z, Wang X, Zhou Z, Zhang H, Chen D, Feng Q, Liang J, LV J, Wang X, Hui Z, Zhang T, Bi N, Deng L, Wang W, Wang L. The Patterns of Failure and Efficacy of Salvage Therapy After Radical Surgery Among Patients With Thoracic Esophageal Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.1023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
93
|
Li C, Deng W, Wang X, Xiao Z, Zhou Z, Zhang H, Chen D, Feng Q, Liang J, Lv J, Wang X, Bi N, Zhang T, Deng L, Wang W. A Phase 1/2 Radiation Dose Escalation Trial Using SIB-IMRT Technique With Concurrent Chemotherapy in Unresectable Esophageal Carcinoma. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.996] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
94
|
Zhai Y, Hui Z, Ma H, Zhao L, LI D, Liang J, Xu L, Bi N, Chen B, Tang Y, Zhou Z, Chen M, Wang L. Continuous Intravenous Infusion Recombinant Human Endostatin Combined with Concurrent Chemoradiation Therapy in Unresectable Stage III Non–small Lung Cancer—Results of a Multicenter Phase 2 Study (NCT01733589). Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.248] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
95
|
Ni W, Yang J, Xiao Z, Wang X, Zhou Z, Zhang H, Chen D, Feng Q, Liang J, LV J, Wang X, Hui Z, Zhang T, Bi N, Deng L, Wang W, Wang L. Adjuvant Treatment is Superior to Salvage Therapy for Pathological T2-3N0M0 or T1-4N1M0/T4N0M0 Esophageal Cancer after Radical Surgery. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.1022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
96
|
Zhai Y, Hui Z, Wang X, Liang J, Wang W, Feng Q, Zhou Z, Wang X, Xiao Z, Bi N, Wang L. Nimotuzumab Combined With Concurrent Chemoradiation Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.1091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
97
|
Ma Y, Xiao J, Bi N, Liu Q, Zhang Y, Zhao R, Yang S, Li Y. Temozolomide combined with fractionated stereotactic radiotherapy for large brain metastases: A propensity-matched Study. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx366.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
98
|
Bi N, Hu M, Xu J, Jia L. Colorimetric determination of mercury(II) based on the inhibition of the aggregation of gold nanorods coated with 6-mercaptopurine. Mikrochim Acta 2017. [DOI: 10.1007/s00604-017-2427-5] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
99
|
Liang J, Bi N, Wu S, Chen M, Lv C, Zhao L, Shi A, Jiang W, Xu Y, Zhou Z, Wang W, Chen D, Hui Z, Lv J, Zhang H, Feng Q, Xiao Z, Wang X, Liu L, Zhang T, Du L, Chen W, Shyr Y, Yin W, Li J, He J, Wang L. Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial. Ann Oncol 2017; 28:777-783. [PMID: 28137739 DOI: 10.1093/annonc/mdx009] [Citation(s) in RCA: 120] [Impact Index Per Article: 17.1] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2016] [Indexed: 12/14/2022] Open
Abstract
Background The optimal chemotherapy regimen administered currently with radiation in patients with stage III non-small cell lung cancer (NSCLC) remains unclear. A multicenter phase III trial was conducted to compare the efficacy of concurrent thoracic radiation therapy with either etoposide/cisplatin (EP) or carboplatin/paclitaxel (PC) in patients with stage III NSCLC. Patients and methods Patients were randomly received 60-66 Gy of thoracic radiation therapy concurrent with either etoposide 50 mg/m2 on days 1-5 and cisplatin 50 mg/m2 on days 1 and 8 every 4 weeks for two cycles (EP arm), or paclitaxel 45 mg/m2 and carboplatin (AUC 2) on day 1 weekly (PC arm). The primary end point was overall survival (OS). The study was designed with 80% power to detect a 17% superiority in 3-year OS with a type I error rate of 0.05. Results A total of 200 patients were randomized and 191 patients were treated (95 in the EP arm and 96 in the PC arm). With a median follow-up time of 73 months, the 3-year OS was significantly higher in the EP arm than that of the PC arm. The estimated difference was 15.0% (95% CI 2.0%-28.0%) and P value of 0.024. Median survival times were 23.3 months in the EP arm and 20.7 months in the PC arm (log-rank test P = 0.095, HR 0.76, 95%CI 0.55-1.05). The incidence of Grade ≥2 radiation pneumonitis was higher in the PC arm (33.3% versus 18.9%, P = 0.036), while the incidence of Grade ≥3 esophagitis was higher in the EP arm (20.0% versus 6.3%, P = 0.009). Conclusion EP might be superior to weekly PC in terms of OS in the setting of concurrent chemoradiation for unresectable stage III NSCLC. Trial registration ID NCT01494558.
Collapse
|
100
|
Hu M, Bi N, Li S, Su T, Hu Q, Ma H, Jia X. Correction: Synthesis and characterization of boron and nitrogen co-doped diamond crystals under high pressure and high temperature conditions. CrystEngComm 2017. [DOI: 10.1039/c7ce90129a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Correction for ‘Synthesis and characterization of boron and nitrogen co-doped diamond crystals under high pressure and high temperature conditions’ by Meihua Hu et al., CrystEngComm, 2017, 19, 4571–4575.
Collapse
|